A detailed history of Teacher Retirement System Of Texas transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 15,823 shares of APLS stock, worth $585,609. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,823
Previous 19,031 16.86%
Holding current value
$585,609
Previous $1.14 Million 18.35%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$55.39 - $72.47 $177,691 - $232,483
-3,208 Reduced 16.86%
15,823 $930,000
Q4 2023

Feb 07, 2024

SELL
$37.14 - $64.82 $151,085 - $263,687
-4,068 Reduced 17.61%
19,031 $1.14 Million
Q3 2023

Oct 31, 2023

BUY
$23.65 - $89.22 $28,450 - $107,331
1,203 Added 5.49%
23,099 $879,000
Q2 2023

Jul 19, 2023

SELL
$76.68 - $93.31 $410,621 - $499,675
-5,355 Reduced 19.65%
21,896 $2 Million
Q1 2023

May 12, 2023

BUY
$46.59 - $66.96 $11,600 - $16,673
249 Added 0.92%
27,251 $1.8 Million
Q4 2022

Feb 10, 2023

SELL
$43.24 - $61.04 $37,186 - $52,494
-860 Reduced 3.09%
27,002 $1.4 Million
Q3 2022

Nov 03, 2022

BUY
$44.76 - $69.66 $698,121 - $1.09 Million
15,597 Added 127.17%
27,862 $1.9 Million
Q2 2022

Aug 09, 2022

SELL
$35.07 - $59.21 $123,797 - $209,011
-3,530 Reduced 22.35%
12,265 $555,000
Q1 2022

May 09, 2022

BUY
$35.46 - $54.12 $41,098 - $62,725
1,159 Added 7.92%
15,795 $803,000
Q4 2021

Feb 10, 2022

BUY
$30.74 - $49.16 $156,312 - $249,978
5,085 Added 53.24%
14,636 $692,000
Q3 2021

Nov 09, 2021

BUY
$31.4 - $69.84 $69,299 - $154,136
2,207 Added 30.05%
9,551 $315,000
Q2 2021

Aug 05, 2021

BUY
$40.9 - $64.9 $45,480 - $72,168
1,112 Added 17.84%
7,344 $464,000
Q1 2021

May 11, 2021

BUY
$40.8 - $57.39 $47,858 - $67,318
1,173 Added 23.19%
6,232 $267,000
Q4 2020

Feb 11, 2021

BUY
$30.79 - $57.2 $155,766 - $289,374
5,059 New
5,059 $289,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $4.07B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.